低剂量CT筛查原发性肺癌对后续脑转移风险的影响
基于国家肺癌筛查试验数据,纳入2002至2009年诊断的原发性肺癌患者1502例,评估低剂量CT筛查检出与脑转移风险的关系。低剂量CT筛查检出者3年脑转移发生率为6.5%,非筛查检出者为11.9%,病因特异性风险比为0.53(P=0.001)。在早期肺癌和接受手术的亚组中,脑转移风险降低同样显著。
要点
- 低剂量CT筛查检出的肺癌患者脑转移风险显著低于非筛查检出者。
- 早期肺癌及接受手术患者中,低剂量CT筛查与脑转移风险降低的关联同样显著。
- 低剂量CT筛查可能通过早期发现肺癌降低后续脑转移风险。
核心结论
- 低剂量CT筛查早期发现原发性肺癌与诊断后脑转移风险降低相关。
研究设计与样本
- 基于国家肺癌筛查试验数据,纳入2002至2009年诊断的原发性肺癌患者1502例,均有脑转移随访数据。
- 采用病因特异性竞争风险回归评估低剂量CT筛查检出与非筛查检出与脑转移风险的关联。
主要发现
- 1502例患者中,41.4%经低剂量CT筛查检出,58.6%经其他方法检出。
- 低剂量CT筛查检出者3年脑转移发生率为6.5%,非筛查检出者为11.9%。
- 调整年龄、分期、组织学和吸烟状态后,病因特异性风险比为0.53(P=0.001)。
- 早期肺癌亚组风险比为0.47(P=0.002),手术亚组风险比为0.37(P=0.001)。
临床怎么用
- 对于肺癌高危人群,低剂量CT筛查有助于早期发现肺癌并可能降低后续脑转移风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Brain metastasis (BM) is one of the most common metastases from primary lung cancer (PLC). Recently, the National Lung Screening Trial revealed the efficacy of low-dose computed tomography (LDCT) screening on LC mortality reduction. Nevertheless, it remains unknown if early detection of PLC through LDCT may be potentially beneficial in reducing the risk of subsequent metastases. Our study aimed to investigate the impact of LDCT screening for PLC on the risk of developing BM after PLC diagnosis. METHODS: We used the National Lung Screening Trial data to identify 1502 participants who were diagnosed with PLC in 2002 to 2009 and have follow-up data for BM. Cause-specific competing risk regression was applied to evaluate an association between BM risk and the mode of PLC detection-that is, LDCT screen-detected versus non-LDCT screen-detected. Subgroup analyses were conducted in patients with early stage PLC and those who underwent surgery for PLC. RESULTS: Of 1502 participants, 41.4% had PLC detected through LDCT screening versus 58.6% detected through other methods, for example, chest radiograph or incidental detection. Patients whose PLC was detected with LDCT screening had a significantly lower 3-year incidence of BM (6.5%) versus those without (11.9%), with a cause-specific hazard ratio (HR) of 0.53 (p = 0.001), adjusting for age at PLC diagnosis, PLC stage, PLC histology, and smoking status. This significant reduction in BM risk among PLCs detected through LDCT screening persisted in subgroups of participants with early stage PLC (HR = 0.47, p = 0.002) and those who underwent surgery (HR = 0.37, p = 0.001). CONCLUSIONS: Early detection of PLC using LDCT screening is associated with lower risk of BM after PLC diagnosis on the basis of a large population-based study.
引用
- Su CC, Wu JT, Neal JW, et al. Impact of Low-Dose Computed Tomography Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis. J Thorac Oncol. 2021. PMID: 34091050. doi:10.1016/j.jtho.2021.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。